Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, which in
turns accounts for the sixth most common cancer worldwide. Despite being the 6 th most …

The most common primary liver cancer is hepatocellular carcinoma (HCC), and its mortality
rate is increasing globally. The overall 5-year survival of patients with liver cancer is …

The limited performance of guideline‐recommended abdominal ultrasound and serum
alpha‐fetoprotein (AFP) highlights the urgent, unmet need for new biomarkers for more …

Even though the combined use of ultrasound (US) and alpha-fetoprotein (AFP) is
recommended for the surveillance of hepatocellular carcinoma (HCC), the utilization of AFP …

Hepatocellular carcinoma (HCC) is a leading cause of cancer‐related mortality worldwide.
Early detection of HCC enables patients to avail curative therapies that can improve patient …

Protein kinases (PKs), one of the largest protein families, can be further divided into different
groups based on their substrate or structure and function. PKs are important signaling …

The role of α‐fetoprotein (AFP) in the surveillance and diagnosis of hepatocellular
carcinoma (HCC) has been questioned in recent years due to its low sensitivity and …

Early diagnosis of cancer is essential for the efficacy of treatment. Our group recently
developed RAPPID, a bioluminescent immunoassay platform capable of measuring a wide …

Objectives: Serum biomarkers are valuable for clinical decision-making for patients with
hepatocellular carcinoma (HCC), among which the most promising are AFP, AFP-L3, DCP …

Background and Objectives: the early diagnosis of hepatocellular carcinoma (HCC) benefits
from the use of alpha-fetoprotein (AFP) together with imaging diagnosis using abdominal …